Johnson, M. L., Smit, E. F., Felip, E., Ramalingam, S. S., Ahn, M.-J., Tsao, A., … Riely, G. J. (2026). A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer. Future Oncol, 22(8), 873–885. https://doi.org/10.1080/14796694.2026.2645982

Johnson, Melissa L., Egbert F. Smit, Enriqueta Felip, Suresh S. Ramalingam, Myung-Ju Ahn, Anne Tsao, Bruce E. Johnson, et al. “A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.” Future Oncol 22, no. 8 (April 2026): 873–85. https://doi.org/10.1080/14796694.2026.2645982.

Johnson ML, Smit EF, Felip E, Ramalingam SS, Ahn M-J, Tsao A, et al. A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer. Future Oncol. 2026 Apr;22(8):873–85.

Johnson, Melissa L., et al. “A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.” Future Oncol, vol. 22, no. 8, Apr. 2026, pp. 873–85. Pubmed, doi:10.1080/14796694.2026.2645982.

Johnson ML, Smit EF, Felip E, Ramalingam SS, Ahn M-J, Tsao A, Johnson BE, Offin M, Hussein M, Dagogo-Jack I, Goldman JW, Clarke JM, Negrao MV, Sanborn RE, Morgensztern D, Usari T, Wilner K, Alejandro L, Rifi N, Zhang X, Riely GJ. A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer. Future Oncol. 2026 Apr;22(8):873–885.